Last year, the Second Circuit issued an opinion in Ony, Inc. v. Cornerstone Therapeutics, Inc., a false advertising case holding that the publication and dissemination of a scientific study that had the effect of touting a company’s product is noncommercial speech and is thereby immune from ...